Abstract
Abstract
Background
As one of the most described epigenetic marks in human cancers, DNA methylation plays essential roles in gene expression regulation and has been implicated in the prognosis and therapeutics of many cancers. We are motivated in this study to explore DNA methylation profiles capturing breast cancer heterogeneity to improve breast cancer prognosis at the epigenetic level.
Results
Through comparisons on differentially methylated CpG sites among breast cancer subtypes followed by a sequential validation and functional studies using computational approaches, we propose 313 CpG, corresponding to 191 genes, whose methylation pattern identifies the triple negative breast cancer subtype, and report cell migration as represented by extracellular matrix organization and cell proliferation as mediated via MAPK and Wnt signalings are the primary factors driving breast cancer subtyping.
Conclusions
Our study offers novel CpGs and gene methylation patterns with translational potential on triple negative breast cancer prognosis, as well as fresh insights from the epigenetic level on breast cancer heterogeneity.
Funder
the Natural Science Foundation of Jiangsu Province
Six Talent Peaks Project in Jiangsu Province
Major Project of Science and Technology in Henan Province
The Technology Development Funding of Wuxi
Fundamental Research Funds for the Central Universities
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Yassi M, Shams Davodly E, Mojtabanezhad Shariatpanahi A, Heidari M, Dayyani M, Heravi-Moussavi A, Moattar MH, Kerachian MA. DMRFusion: a differentially methylated region detection tool based on the ranked fusion method. Genomics. 2018;110(6):366–74.
2. Jin B, Li Y, Robertson KD. DNA methylation: superior or subordinate in the epigenetic hierarchy? Genes Cancer. 2011;2(6):607–17.
3. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glockner S, Piantadosi S, Gabrielson E, Pridham G, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med. 2008;358(11):1118–28.
4. Leygo C, Williams M, Jin H, Chan M, Chu W, Grusch M, Cheng Y. DNA methylation as a noninvasive epigenetic biomarker for the detection of Cancer. Dis Markers. 2017;2017(1):3726595.
5. Xiaoke H, Huiyan L, Michal K, Wei W, Wenqiu W, Juan W, Ken F, Jiayi H, Heng Z, Shaohua Y. DNA methylation markers for diagnosis and prognosis of common cancers. Proc Natl Acad Sci U S A. 2017;114(28):7414–9.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献